Atlas Trials

Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)

Clinical trial NCT06551233 · RECRUITING

Trial details

NCT number
NCT06551233
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2024-04-22
Primary completion
2024-11-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.